Vivid Seats (SEAT)
(Delayed Data from NSDQ)
$5.84 USD
+0.16 (2.82%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $5.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Income Statements
Fiscal Year end for Vivid Seats Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 713 | 600 | 443 | 0 | 469 |
Cost Of Goods | 182 | 141 | 91 | 0 | 106 |
Gross Profit | 531 | 460 | 352 | 0 | 363 |
Selling & Adminstrative & Depr. & Amort Expenses | 449 | 382 | 276 | 1 | 373 |
Income After Depreciation & Amortization | 81 | 78 | 77 | -1 | -10 |
Non-Operating Income | 3 | 4 | -37 | 0 | -2 |
Interest Expense | 14 | 13 | 58 | 0 | 42 |
Pretax Income | 71 | 69 | -19 | -1 | -54 |
Income Taxes | -42 | -2 | 0 | 0 | 0 |
Minority Interest | 39 | 42 | -3 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 113 | 71 | -19 | -1 | -54 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 75 | 29 | -16 | -1 | -54 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 100 | 89 | 83 | -1 | 86 |
Depreciation & Amortization (Cash Flow) | 19 | 11 | 7 | 0 | 96 |
Income After Depreciation & Amortization | 81 | 78 | 77 | -1 | -10 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 198.88 | 198.74 | 77.50 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.26 | 0.36 | -0.04 | NA | NA |
Diluted Net EPS (GAAP) | 0.26 | 0.36 | -0.04 | -0.04 | NA |
Fiscal Year end for Vivid Seats Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 198.30 | 188.13 | 165.38 | 161.06 | 164.99 |
Cost Of Goods | 51.35 | 50.46 | 42.62 | 37.76 | 38.30 |
Gross Profit | 146.96 | 137.67 | 122.76 | 123.30 | 126.69 |
SG&A, R&D, and Dept/Amort Expenses | 136.86 | 117.55 | 105.15 | 89.79 | 101.93 |
Income After SG&A, R&D, and Dept/Amort Expenses | 10.10 | 20.12 | 17.61 | 33.51 | 24.76 |
Non-Operating Income | 2.74 | 1.04 | -1.00 | 0.33 | 1.61 |
Interest Expense | 4.91 | 2.54 | 2.77 | 3.28 | 3.32 |
Pretax Income | 7.93 | 18.61 | 13.84 | 30.56 | 23.05 |
Income Taxes | -20.59 | 2.60 | -24.49 | 0.29 | -1.78 |
Minority Interest | 21.65 | 9.34 | 7.61 | 0.00 | 14.75 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 28.53 | 16.02 | 38.33 | 30.27 | 24.83 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 6.87 | 6.68 | 30.71 | 30.27 | 10.09 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | NA | 96.86 | 196.38 | 195.82 | 198.81 |
Diluted EPS Before Non-Recurring Items | NA | 0.07 | 0.20 | 0.15 | 0.13 |
Diluted Net EPS (GAAP) | -0.16 | 0.07 | 0.20 | 0.15 | 0.13 |